VISIPAQUE 270 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Visipaque 270, and when can generic versions of Visipaque 270 launch?
Visipaque 270 is a drug marketed by Ge Healthcare and is included in two NDAs.
The generic ingredient in VISIPAQUE 270 is iodixanol. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iodixanol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Visipaque 270
A generic version of VISIPAQUE 270 was approved as iodixanol by HENGRUI PHARMA on May 19th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VISIPAQUE 270?
- What are the global sales for VISIPAQUE 270?
- What is Average Wholesale Price for VISIPAQUE 270?
Summary for VISIPAQUE 270
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 31 |
Patent Applications: | 4,457 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VISIPAQUE 270 at DailyMed |
![VISIPAQUE 270 drug patent expirations Drug patent expirations by year for VISIPAQUE 270](/p/graph/s/t/VISIPAQUE_270-patent-expirations.png)
Recent Clinical Trials for VISIPAQUE 270
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Institute of Liver and Biliary Sciences, India | N/A |
Guerbet | Phase 1 |
University of Washington | Phase 1 |
Pharmacology for VISIPAQUE 270
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for VISIPAQUE 270
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VISIPAQUE 270
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020808-001 | Aug 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VISIPAQUE 270
See the table below for patents covering VISIPAQUE 270 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
German Democratic Republic | 295992 | KONTRASTMITTEL | ⤷ Sign Up |
Austria | 371998 | ⤷ Sign Up | |
Turkey | 25111 | KONTRAST ORTAMI | ⤷ Sign Up |
Hong Kong | 1003563 | ⤷ Sign Up | |
Hungary | T62490 | ⤷ Sign Up | |
South Korea | 830001643 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VISIPAQUE 270
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0108638 | 97C0101 | Belgium | ⤷ Sign Up | PRODUCT NAME: IODIXANOL; NAT. REGISTRATION NO/DATE: 914 IS 204 F 12 19970325; FIRST REGISTRATION: SE 11758 19930205 |
0108638 | SPC/GB93/150 | United Kingdom | ⤷ Sign Up | SPC/GB93/150, 20031107, EXPIRES: 20080330 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |